Obseva SA (NASDAQ:OBSV)
| 1.66 Delayed Data As of Jun 29 |  -0.04 / -2.33%Today’s Change | 1.08 Today|||52-Week Range 3.58 | -16.58% Year-to-Date |
Latest OBSV News | Press Releases
| ObsEva's (OBSV) Yselty Gets EU Nod to Treat Uterine Fibroids Jun 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.72 |
| Today’s open | 1.71 |
| Day’s range | 1.63 - 1.71 |
| Volume | 516,502 |
| Average volume (3 months) | 517,652 |
| Market cap | $154.4M |
Data as of 3:59pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | +53.44% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTXRCitius Pharmaceutica... | -0.04 | -3.69% |
| AVDLAvadel Pharmaceutica... | 0.00 | 0.00% |
| ---- | ||
| FSTXF-Star Therapeutics ... | +0.06 | +0.96% |
Data as of 5:26pm ET, 06/29/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$58.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Geneva, Geneve (geneva) |
Forecasts
